Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology
The partnership will bring the power of Ibex clinical-grade AI algorithms into Dedalus end-to-end digital pathology solution
Milan, March 10th 2022 – Dedalus Group (“Dedalus”), the leading healthcare and diagnostic software solutions provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announce a strategic partnership to bring the power of artificial intelligence to digital pathology.
The partnership will bring the power of Ibex clinical-grade AI algorithms into Dedalus end-to-end digital pathology solution. This will benefit pathologists and patients through enhanced quality of diagnosis, at speed.
The increasing demand for pathology services posed by the growing number of cancer patients and global shortage of trained pathologists, leads pathology laboratories to actively seek efficiency-enhancing solutions that enable to maintain high accuracy levels and reduce time to diagnosis.
